Patent restoration and the cost of pharmaceuticals . : YN5-156/2018E-PDF
"This report estimates additional drug costs to Canadian consumers from changes to the Patent Law as negotiated under the Canada-European Union Comprehensive Economic and Trade Agreement (CETA). A two-year certificate of supplementary protection (CSP; elsewhere termed patent restoration, and used synonymously here since CSP provides patent-like protection) will delay the introduction of generic alternatives, and likely keep prices higher than they otherwise would be. The report also estimates the fiscal cost to the federal government of compensating provinces for increased costs to provincial public drug programs”--Verso of cover.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.856574&sl=1
| Ministère/Organisme | Canada. Office of the Parliamentary Budget Officer. |
|---|---|
| Titre | Patent restoration and the cost of pharmaceuticals . |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: La prolongation de la durée des brevets et le coût des médicaments. Cover title. "26 April 2018." Includes bibliographical references. |
| Information sur la publication | Ottawa : Office of the Parliamentary Budget Officer, 2018. |
| Description | 41 p. : col. charts |
| Numéro de catalogue |
|
| Descripteurs | Drugs Prices Patent extensions Government policy |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.- Date de modification :